Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD - Get Free Report) shares passed below its 200-day moving

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 121.2% to $6.99 during Monday'

Aramchol meglumine is the only SCD1 inhibitor with an established clinical safety profile and confir

Galmed Pharmaceuticals (NASDAQ: GLMD - Get Free Report) is expected to issue its results before the

Crown Holdings Inc (CCK) stock gained 16.4% in pre-market trading after reporting strong Q2 results

Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 25.1% to $3.79 during Monday&

Galmed has developed, in collaboration with Barcode Nanotech, a unique proprietary lipid nanoparticl

Galmed has developed, in collaboration with Barcode Nanotech, a unique proprietary lipid nanoparticl

Gainers Q32 Bio (NASDAQ:QTTB) stock moved upwards by 44.4% to $16.19 during Friday's after-mark

Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 40.9% to $0.16 during Thursday's pre-

Gainers Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. T

Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 40.3% to $4.56 during Tuesday's after-m

Colospan Ltd. ("Colospan") provides Galmed Pharmaceuticals Ltd.

Transaction will add FDA Breakthrough Device-Designated technology with active U.S. pivotal IDE tria

- Tissue Dynamics identified a previously unrecognized metabolic mechanism driving cardiac fibrosis

Results from Study AM-001 mark a pivotal advance through the transition to a once daily lower 400mg

Novel vascularized, sensor-embedded cardiac organoid model will focus on chronic post-MI remodeling

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD - Get Free Report) was the target of a large growth in sho

Recently, Galmed announced breakthrough medicinal chemistry work converting Aramchol into a brain-pe

Clearsign Technologies Corp (NASDAQ: CLIR) shares rose 11.3% in pre-market trading after reporting b

Galmed said it developed a new formulation of its SCD1 inhibitor, Aramchol, designed to cross the bl

98% of drugs do not reach the brain, as the blood–brain barrier (BBB) separates peripheral blood cir

TEL AVIV, Israel, March 31, 2026 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed

Surrozen (NASDAQ: SRZN - Get Free Report) and Galmed Pharmaceuticals (NASDAQ: GLMD - Get Free Report

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD - Get Free Report) was the recipient of a large decrease i

TEL AVIV, Israel, Jan. 30, 2026 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed"

Late Breaking Abstract titled "Targeting SCD1 enhances activity of standard of care regorafenib in h

The new patent granted in South Korea is added to earlier patents already granted by the United Stat

TEL AVIV, Israel , Dec. 1, 2025 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed"

  On Tuesday, 647 companies set new 52-week lows.

  On Monday, 369 companies set new 52-week lows.

  On Tuesday, 386 stocks made new 52-week lows.

  During Thursday's session, 92 stocks hit new 52-week lows.

Gainers

  On Thursday, 930 stocks hit new 52-week lows.

  On Tuesday, 456 stocks hit new 52-week lows.

  On Thursday, 49 companies reached new 52-week lows.

  On Tuesday, 951 companies hit new 52-week lows.

  On Wednesday, 216 stocks hit new 52-week lows.